These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12518463)

  • 1. [Aberrant high expression of B lymphocyte chemoattractant (BLC/CXCL13) in a murine model for SLE].
    Ishikawa S
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2369-74. PubMed ID: 12518463
    [No Abstract]   [Full Text] [Related]  

  • 2. Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus.
    Sato T; Ishikawa S; Akadegawa K; Ito T; Yurino H; Kitabatake M; Yoneyama H; Matsushima K
    Eur J Immunol; 2004 Dec; 34(12):3346-58. PubMed ID: 15495164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC.
    Ishikawa S; Nagai S; Sato T; Akadegawa K; Yoneyama H; Zhang YY; Onai N; Matsushima K
    Eur J Immunol; 2002 Jul; 32(7):1881-7. PubMed ID: 12115607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant B1 cell trafficking in a murine model for lupus.
    Ishikawa S; Matsushima K
    Front Biosci; 2007 Jan; 12():1790-803. PubMed ID: 17127421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC.
    Ishikawa S; Sato T; Abe M; Nagai S; Onai N; Yoneyama H; Zhang Y; Suzuki T; Hashimoto S; Shirai T; Lipp M; Matsushima K
    J Exp Med; 2001 Jun; 193(12):1393-402. PubMed ID: 11413194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo.
    Vissers JL; Hartgers FC; Lindhout E; Figdor CG; Adema GJ
    Eur J Immunol; 2001 May; 31(5):1544-9. PubMed ID: 11465112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
    Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
    Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diseases of autoimmunity.
    Dixon FJ
    Natl Cancer Inst Monogr; 1982; 60():181-92. PubMed ID: 6214718
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of lymphocyte migration to the murine spleen after marginal zone macrophage phagocytosis of blood-borne particulate material.
    Bruce Lyons A; Watkins M; Simpson CC; Konrad Muller H
    Immunol Invest; 2006; 35(1):75-92. PubMed ID: 16531331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of homeostatic chemokine expression and cell trafficking during immune responses.
    Mueller SN; Hosiawa-Meagher KA; Konieczny BT; Sullivan BM; Bachmann MF; Locksley RM; Ahmed R; Matloubian M
    Science; 2007 Aug; 317(5838):670-4. PubMed ID: 17673664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune aspects of systemic lupus erythematosus.
    Theofilopoulos AN; Prud'Homme GJ; Dixon FJ
    Concepts Immunopathol; 1985; 1():190-218. PubMed ID: 3916403
    [No Abstract]   [Full Text] [Related]  

  • 13. B-Cells in ocular adnexal lymphoproliferative lesions express B-cell attracting chemokine 1 (CXCL13).
    Falkenhagen KM; Braziel RM; Fraunfelder FW; Smith JR
    Am J Ophthalmol; 2005 Aug; 140(2):335-7. PubMed ID: 16086967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum level of selected chemokines in systemic lupus erythematosus patients taking into consideration the peripheral blood leukocyte counts].
    Kopczyńska M; Franek A; Błaszczak E; Dworak J; Kopczyński P; Hrycek A
    Pol Merkur Lekarski; 2013 May; 34(203):251-4. PubMed ID: 23894774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the thymus in murine lupus and cellular transfer of the disease.
    Theofilopoulos AN
    Arthritis Rheum; 1982 Jul; 25(7):726-33. PubMed ID: 6213235
    [No Abstract]   [Full Text] [Related]  

  • 17. Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus.
    Ito T; Ishikawa S; Sato T; Akadegawa K; Yurino H; Kitabatake M; Hontsu S; Ezaki T; Kimura H; Matsushima K
    J Immunol; 2004 Mar; 172(6):3628-34. PubMed ID: 15004165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus.
    Jacobi AM; Diamond B
    J Exp Med; 2005 Aug; 202(3):341-4. PubMed ID: 16061723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of suppressor T cell functions in SLE].
    Sakane T
    Nihon Rinsho; 1983; 41(4):766-73. PubMed ID: 6224950
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].
    Zou CH; Tian L; Wei YQ; Zhao X; Kan B; Yang JL; Mao YQ; Wen YJ; Li J; Deng HX
    Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.